UnitedHealth Group and Amedisys asked a federal judge Wednesday to either dismiss a government lawsuit over their planned merger or require the Justice Department to better define where the deal ...

Amedisys (NASDAQ:AMED) quickly dropped 4% after a report that the Dept. of Justice is leaning toward filing a lawsuit to challenge UnitedHealthcare's (UNH) planned acquisition. The regulator could ...

UnitedHealth Group (NYSE:UNH) and Amedisys (NASDAQ:AMED) have each agreed to waive their right to terminate their previously announced merger agreement, a decision that could delay the transaction ...

LHC and Amedisys are two of the biggest home health ... including the relationship between insurer UnitedHealthcare and health services division Optum. Meanwhile, the Federal Trade Commission ...

In a report released on January 29, Whit Mayo from Leerink Partners reiterated a Hold rating on Amedisys (AMED – Research Report), with a price target of $101.00. Whit Mayo has given his Hold ...

The deal, disclosed in June, was meant to offload assets as UnitedHealth and Amedisys explored a merger.

UnitedHealth Group and Amedisys have asked the courts to dismiss the federal government's challenge to their $3.3 billion merger, arguing that the Department of Justice (DOJ) has not made a clear ...

Health insurer United Health and Amedisys had been in talks for a $3.3 billion merger. In November, the Justice Department filed an antitrust lawsuit to block that merger. Amedisys' expected ...

Amedisys, Inc. (NASDAQ:AMED – Free Report) – Research analysts at Leerink Partnrs cut their FY2024 earnings estimates for Amedisys in a note issued to investors on Wednesday, January 29th.

Health insurer UnitedHealth and home health company Amedisys were, at that time, in talks for a $3.3 billion merger. In November, the Justice Department filed an antitrust lawsuit to block the merger.